Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific differences in the prognostic value of ischemic pre-hospital ECGs.

Frontiers in cardiovascular medicine·2026
Same author

Patient and physician outcomes of a store-and-forward teledermatology application in Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient-reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Suppression of natural lens fluorescence in fundus autofluorescence measurements: review of hardware solutions.

Biomedical optics express·2022
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

3.1K

[Psoriasis-associated keratitis: case report].

F S Filev1, V G Herbert, B Lögering

  • 1UKE-Augenklinik, Universitätsklinikum Hamburg-Eppendorf, Hummelsbütteler Kirchenweg 75, 22339, Hamburg, Deutschland, flip_flev@yahoo.com.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|September 24, 2014
PubMed
Summary
This summary is machine-generated.

Psoriasis can affect the eyes, causing a rare condition called psoriasis-associated keratitis. Systemic immunomodulatory therapy effectively treated this ocular manifestation in a patient case.

More Related Videos

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

3.1K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.8K

Area of Science:

  • Ophthalmology
  • Dermatology
  • Immunology

Background:

  • Psoriasis is a chronic inflammatory skin condition.
  • It is frequently linked to systemic and extracutaneous manifestations.
  • Ocular involvement in psoriasis is uncommon but significant.

Observation:

  • A case report details a 37-year-old male patient with psoriasis.
  • The patient presented with a rare ocular manifestation: psoriasis-associated keratitis.
  • This condition involves inflammation of the cornea due to psoriasis.

Findings:

  • Systemic immunomodulatory therapy was administered to the patient.
  • The therapy resulted in rapid and significant improvement of the ocular symptoms.
  • This suggests a positive response to systemic treatment for psoriasis-associated keratitis.

Implications:

  • Psoriasis-associated keratitis is a treatable ocular condition.
  • Systemic immunomodulatory therapy is a viable treatment option.
  • Early diagnosis and treatment can prevent vision loss in psoriatic patients.